Daniel Kontoh-Boateng | Investor Relations |
Lisa Ricciardi | President and Chief Executive Officer |
Andrew Einhorn | Interim Chief Financial Officer |
Tony Caggiano | Chief Medical Officer and Head of R&D |
Charles Duncan | Cantor Fitzgerald |
Jay Olson | Oppenheimer |
Mayank Mamtani | B. Riley Securities |
Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Incorporated Fourth Quarter and Fiscal Year 2022 Earnings Conference Call. My name is Julianne and I will be your conference operator today. This call is being recorded.
I would like to turn the presentation over now to your host for today's call, Daniel Kontoh-Boateng, Investor Relations for Cognition Therapeutics. Please go ahead, Mr.